Related Experiment Videos
Molecular targets in the National Cancer Institute drug screen
S E Bates1, A T Fojo, J N Weinstein
1Medicine Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Journal of Cancer Research and Clinical Oncology
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.
Biochemical pharmacology·2010
Complementary, alternative, integrative, or unconventional medicine?
The oncologist·2001
Losing God.
The oncologist·2001
Caring for colleagues.
The oncologist·2001
Medical mistakes: a workshop on personal perspectives.
The oncologist·2001
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Comment on "Treatment of retroperitoneal sarcoma in Germany between 2000 and 2022: a retrospective analysis from the German Cancer Registry Group".
Journal of cancer research and clinical oncology·2026
Comment on "Theranostic lipid nanocarriers for precision diagnosis and targeted therapy in pancreatic ductal adenocarcinoma".
Journal of cancer research and clinical oncology·2026
Sleep quality and disturbances in adolescents and young adults with cancer compared to a healthy comparison group: results of the AYA-LE study.
Journal of cancer research and clinical oncology·2026
Upper- versus lower-extremity synovial sarcoma: distinct surgical pathways and postoperative morbidity in a 24-year cohort.
Journal of cancer research and clinical oncology·2026
Time to subsequent therapy (TTST) as an endpoint in clinical studies: development of standardized documentation of subsequent therapy through systematic literature review, expert interviews, and Delphi survey.
Journal of cancer research and clinical oncology·2026